feed,title,long_url,short_url
Benzinga,Ocuphire Pharma Stock Surges After Nyxol Combo Treatment Meets Study Endpoints In Presbyopic Patients,https://benzinga.com/general/biotech/21/06/21784080/ocuphire-pharma-stock-surges-after-nyxol-combo-treatment-meets-study-endpoints-in-presbyopic-pati,https://j.mp/3AdRdkw
